Atıf İçin Kopyala
Nuhoğlu Kantarcı E., Tolgay E., EŞKAZAN A. E.
Cancer, cilt.129, sa.17, ss.2610-2612, 2023 (SCI-Expanded)
-
Yayın Türü:
Makale / Editöre Mektup
-
Cilt numarası:
129
Sayı:
17
-
Basım Tarihi:
2023
-
Doi Numarası:
10.1002/cncr.34938
-
Dergi Adı:
Cancer
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Abstracts in Social Gerontology, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Public Affairs Index, Veterinary Science Database
-
Sayfa Sayıları:
ss.2610-2612
-
Bursa Uludağ Üniversitesi Adresli:
Evet
Özet
In an era when tyrosine kinase inhibitors are gaining acceptance in the treatment scene of chronic-phase chronic myeloid leukemia, this editorial focuses on the search for the optimal patient-based frontline treatment option while evaluating a recent study by Tiribelli and colleagues, which is published in this issue of Cancer.